New frontier in renal denervation: data, devices and developments

Facilitators: R. M. Bruno, K. Tsioufis

Summary

Advance your understanding of renal denervation with the latest data, innovative devices, and emerging developments. This session reviews the 12-month results of the REDUCED 1 trial evaluating the TIVUS system, explores safety and efficacy of novel renal stimulation techniques, and presents outcomes from registries including patients with chronic kidney disease. Long-term effects on blood pressure and mortality are also discussed, providing a comprehensive update on this evolving therapy.

Presentations available when logged in:

  • 12-month results of the REDUCED 1 trial assessing the TIVUS system in renal denervation
  • Safety and efficacy of renal stimulation with direct wire pacing technique during renal denervation
  • Independent, single-center RDN registry: results in CKD patients
  • Long-term effect of renal denervation on blood pressure and all-cause mortality